Nirmatrelvir-ritonivir, COVID-19, and possible adverse cutaneous reactions.

Albrecht, J Mark; Cooper, Benjamin R; Waller, Jacquelyn D; Presley, Colby L; Pulsipher, Kayd J; Rundle, Chandler W; Dellavalle, Robert P

Albrecht, J Mark; Cooper, Benjamin R; Waller, Jacquelyn D; Presley, Colby L; Pulsipher, Kayd J; Rundle, Chandler W; Dellavalle, Robert P.

Affiliation

Dellavalle RP; Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA Dermatology Service, U.S. Department of Veterans Affairs Rocky Mountain Regional Medical Center, Aurora, Colorado, USA. Robert.dellavalle@ucdenver.edu.

Dermatol Online J ; 29(1)2023 Feb 15.

Article in En | MEDLINE | ID: mdl-37040906

Subject(s)

COVID-19; Drug-Related Side Effects and Adverse Reactions; Humans; Ritonavir; Lactams

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug-Related Side Effects and Adverse Reactions / COVID-19 Limits: Humans Language: En Journal: Dermatol Online J Journal subject: DERMATOLOGIA Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google